Will molecular diagnosis of drug-resistant tuberculosis improve patient outcomes?

Int J Tuberc Lung Dis. 2012 Jan;16(1):4-5. doi: 10.5588/ijtld.11.0419.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Antitubercular Agents / therapeutic use*
  • Developing Countries
  • Drug Resistance, Multiple, Bacterial*
  • Female
  • Health Services Accessibility*
  • Healthcare Disparities
  • Humans
  • Microbial Sensitivity Tests*
  • Molecular Diagnostic Techniques*
  • Mycobacterium tuberculosis / drug effects*
  • Mycobacterium tuberculosis / genetics
  • Mycobacterium tuberculosis / isolation & purification*
  • Predictive Value of Tests
  • Quality of Health Care
  • South Africa
  • Time Factors
  • Treatment Outcome
  • Tuberculosis, Multidrug-Resistant / diagnosis*
  • Tuberculosis, Multidrug-Resistant / drug therapy*
  • Tuberculosis, Multidrug-Resistant / microbiology
  • Young Adult

Substances

  • Antitubercular Agents